Switch to:
More From Other Websites
AstraZeneca PLC (ADR) (AZN)’s Lynparza Trial Results Positive In Competitive Threat To Clovis... Mar 16 2017
Tesaro Sell-Off On AstraZeneca Ovarian Cancer Trial Overdone: Analyst Mar 15 2017
Here’s What Just Happened With AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO) And Clovis Oncology... Mar 15 2017
AstraZeneca Ovarian Cancer Drug Succeeds in Trial Mar 15 2017
Lynparza Vs. Niraparib Mar 15 2017
Wedbush Cuts TESARO Target By 18% Following SOLO-2 Results Mar 15 2017
Why Tesaro is Tanking Mar 14 2017
AstraZeneca ovarian cancer drug slows disease markedly in study Mar 14 2017
AstraZeneca ovarian cancer drug slows disease markedly in study Mar 14 2017
Tesaro Announces Presentation of Niraparib Phase 3 ENGOT-OV16/NOVA Trial Secondary Endpoint Results... Mar 13 2017
TESARO Announces Niraparib Data Presentations at the 2017 SGO Annual Meeting on Women’s Cancer Mar 12 2017
Blog Coverage CEL-SCI Provides Update on Late-stage Multikine Head and Neck Cancer Study Mar 08 2017
TESARO, Inc. :TSRO-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017 Mar 06 2017
TESARO, INC. Financials Mar 04 2017
TESARO, Inc. :TSRO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017 Mar 03 2017
Tesaro Shares Could Jump On A Buyout Offer Mar 02 2017
Do Options Traders Know Something About Tesaro (TSRO) Stock We Don't? Mar 02 2017
Tesaro Eyes Immuno-Oncology As AstraZeneca, Clovis Loom: Analyst Mar 01 2017
Edited Transcript of TSRO earnings conference call or presentation 28-Feb-17 9:15pm GMT Feb 28 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK